230 related articles for article (PubMed ID: 16197967)
1. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
Ledzewicz U; Schättler H
Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
[TBL] [Abstract][Full Text] [Related]
2. Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model.
Iliadis A; Barbolosi D
Comput Biomed Res; 2000 Jun; 33(3):211-26. PubMed ID: 10860586
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls.
de Pillis LG; Gu W; Fister KR; Head T; Maples K; Murugan A; Neal T; Yoshida K
Math Biosci; 2007 Sep; 209(1):292-315. PubMed ID: 17306310
[TBL] [Abstract][Full Text] [Related]
4. [Dosage regimen optimization in cancer chemotherapy using a mathematical model].
Barbolosi D; Freyer G; Ciccolini J; Iliadis A
Bull Cancer; 2003 Feb; 90(2):167-75. PubMed ID: 12660135
[TBL] [Abstract][Full Text] [Related]
5. Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function.
Engelhart M; Lebiedz D; Sager S
Math Biosci; 2011 Jan; 229(1):123-34. PubMed ID: 21129386
[TBL] [Abstract][Full Text] [Related]
6. On optimal delivery of combination therapy for tumors.
d'Onofrio A; Ledzewicz U; Maurer H; Schättler H
Math Biosci; 2009 Nov; 222(1):13-26. PubMed ID: 19706298
[TBL] [Abstract][Full Text] [Related]
7. Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment.
Ledzewicz U; Marriott J; Maurer H; Schättler H
Math Med Biol; 2010 Jun; 27(2):157-79. PubMed ID: 20513667
[TBL] [Abstract][Full Text] [Related]
8. Nonlinear model predictive control for dosing daily anticancer agents using a novel saturating-rate cell-cycle model.
Florian JA; Eiseman JL; Parker RS
Comput Biol Med; 2008 Mar; 38(3):339-47. PubMed ID: 18222419
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
[TBL] [Abstract][Full Text] [Related]
10. Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy.
Ledzewicz U; Maurer H; Schättler H
Math Biosci Eng; 2011 Apr; 8(2):307-23. PubMed ID: 21631132
[TBL] [Abstract][Full Text] [Related]
11. [Action of levamisole on bone marrow repair in patients undergoing anticancer chemotherapy].
Dujardin P; Lods JC; Cassuto JP; Audoly P
Therapie; 1976; 31(6):733-8. PubMed ID: 1025779
[No Abstract] [Full Text] [Related]
12. Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity.
Wang S; Schattler H
Math Biosci Eng; 2016 Dec; 13(6):1223-1240. PubMed ID: 27775377
[TBL] [Abstract][Full Text] [Related]
13. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
Boldrini JL; Costa MI
IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
[TBL] [Abstract][Full Text] [Related]
14. Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours.
Trocòniz IF; Garrido MJ; Segura C; Cendrós JM; Principe P; Peraire C; Obach R
Cancer Chemother Pharmacol; 2006 Jun; 57(6):727-35. PubMed ID: 16261364
[TBL] [Abstract][Full Text] [Related]
15. Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis.
Schättler H; Ledzewicz U; Cardwell B
Math Biosci Eng; 2011 Apr; 8(2):355-69. PubMed ID: 21631134
[TBL] [Abstract][Full Text] [Related]
16. Optimal intervention strategies for cyclic therapeutic methods.
Vahedi G; Faryabi B; Chamberland JF; Datta A; Dougherty ER
IEEE Trans Biomed Eng; 2009 Feb; 56(2):281-91. PubMed ID: 19272947
[TBL] [Abstract][Full Text] [Related]
17. Modelling and simulation of chemotherapy of haematological and gynaecological cancers.
Nani FK; Oğuztöreli MN
IMA J Math Appl Med Biol; 1999 Mar; 16(1):39-91. PubMed ID: 10335600
[TBL] [Abstract][Full Text] [Related]
18. Regression and regrowth of tumour cords following single-dose anticancer treatment.
Bertuzzi A; D'Onofrio A; Fasano A; Gandolfi A
Bull Math Biol; 2003 Sep; 65(5):903-31. PubMed ID: 12909255
[TBL] [Abstract][Full Text] [Related]
19. An integrated network-based mechanistic model for tumor growth dynamics under drug administration.
Ribeiro D; Pinto JM
Comput Biol Med; 2009 Apr; 39(4):368-84. PubMed ID: 19285661
[TBL] [Abstract][Full Text] [Related]
20. Modeling and optimization of combined cytostatic and cytotoxic cancer chemotherapy.
Villasana M; Ochoa G; Aguilar S
Artif Intell Med; 2010 Nov; 50(3):163-73. PubMed ID: 20620035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]